Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.

Wilson, C A; di Clemente, N; Ehrenfels, C; Pepinsky, R B; Josso, N; Vigier, B; Cate, R L

Wilson, C A; di Clemente, N; Ehrenfels, C; Pepinsky, R B; Josso, N; Vigier, B; Cate, R L.

Affiliation

Wilson CA; Biogen, Inc., Cambridge, Massachusetts 02142.

Mol Endocrinol ; 7(2): 247-57, 1993 Feb.

Article in En | MEDLINE | ID: mdl-8469238

Subject(s)

Glycoproteins; Growth Inhibitors/chemistry; Mullerian Ducts/drug effects; Multigene Family; Peptide Fragments/pharmacology; Testicular Hormones/chemistry; Transforming Growth Factor beta; Animals; Anti-Mullerian Hormone; Antibodies, Monoclonal/immunology; Aromatase/biosynthesis; CHO Cells; Cattle; Cricetinae; Enzyme Induction/drug effects; Female; Fibrinolysin/metabolism; Growth Inhibitors/immunology; Growth Inhibitors/pharmacology; Humans; Ovary/embryology; Ovary/enzymology; Protein Folding; Rats; Recombinant Proteins/pharmacology; Testicular Hormones/immunology; Testicular Hormones/pharmacology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Testicular Hormones / Glycoproteins / Multigene Family / Transforming Growth Factor beta / Growth Inhibitors / Mullerian Ducts Type of study: Diagnostic_studies Limits: Animals / Female / Humans Language: En Journal: Mol Endocrinol Journal subject: BIOLOGIA MOLECULAR / ENDOCRINOLOGIA Year: 1993 Type: Article

Search on Google

XML

PubMed Links